Market Overview

Benzinga's Top Upgrades, Downgrades For August 29, 2017

Share:
Related KITE
Life (Science) Lessons: The Hows And Whos To Play Biotech
Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead
Let's Talk About CAR-T (GuruFocus)
Related INFY
Benzinga's Top Upgrades, Downgrades For September 18, 2017
The Market In 5 Minutes
Yacktman Fund Adds to Infosys, Curbs Oracle, Exits Staples (GuruFocus)

Top Upgrades

  • Wedbush upgraded Kite Pharma Inc (NASDAQ: KITE) from Underperform to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Wedbush upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Neutral to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.
  • Bank of America upgraded Heico Corp (NYSE: HEI) from Neutral to Buy. HEICO shares dropped 1.30 percent to close at $83.25 on Monday.
  • Analysts at Raymond James upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Market Perform to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.


Top Downgrades

  • Analysts at FBR Capital downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Neutral. Finish Line shares fell 29.6 percent to $7.34 in pre-market trading.
  • Canaccord Genuity downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Chardan Capital downgraded Intellia Therapeutics Inc (NASDAQ: NTLA) from Buy to Neutral. Intellia Therapeutics shares dropped 2.45 percent to $20.31 in pre-market trading.
  • Axiom Capital downgraded JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Hold to Sell. JA Solar shares closed at $6.38 on Monday.
  • BTIG downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Bank of America downgraded Cemex SAB de CV (ADR) (NYSE: CX) from Buy to Neutral. Cemex shares fell 0.11 percent to close at $9.12 on Monday.
  • JMP Securities downgraded Loxo Oncology Inc (NASDAQ: LOXO) from Market Outperform to Market Perform. Loxo Oncology shares rose 5.89 percent to close at $78.56 on Monday.
  • SunTrust Robinson Humphrey downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.

 


Top Initiations

 

  • Analysts at Macquarie initiated coverage on Carter's, Inc. (NASDAQ: CRI) with an Outperform rating. Carter's shares closed at $85.92 on Monday.
  • Brean Capital initiated coverage on CenterState Banks Inc (NASDAQ: CSFL) with a Hold rating. CenterState Banks shares closed at $24.73 on Monday.
  • Nomura initiated coverage on AveXis Inc (NASDAQ: AVXS) with a Reduce rating. The price target for AveXis is set to $52. AveXis shares closed at $96.98 on Monday.
  • Analysts at Chardan Capital initiated coverage on Tivity Health Inc (NASDAQ: TVTY) with a Neutral rating. The price target for Tivity Health is set to $40. Tivity Health shares closed at $37.55 on Monday.
  • KLR Group initiated coverage on Ultra Petroleum Corp. (NYSE: UPL) with a Buy rating. The price target for Ultra Petroleum is set to $14. Ultra Petroleum shares closed at $7.61 on Monday.
  • Analysts at Citi initiated coverage of Venator Materials PLC (NYSE: VNTR) with a Buy rating. The price target for Venator Materials is set to $24. Venator Materials shares closed at $20.05 on Monday.
  • Analysts at Aegis Capital initiated coverage on DarioHealth Corp (NASDAQ: DRIO) with a Buy rating. The price target for DarioHealth is set to $3.50. DarioHealth shares closed at $2.00 on Monday.
  • Bank of America initiated coverage on Helen of Troy Limited (NASDAQ: HELE) with an Underperform rating. The price target for Helen of Troy is set to $87. Helen of Troy shares closed at $96.85 on Monday.

Latest Ratings for KITE

DateFirmActionFromTo
Aug 2017WedbushUpgradesUnderperformNeutral
Aug 2017Canaccord GenuityDowngradesBuyHold
Aug 2017SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for KITE
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (CRI + AVXS)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...